If You're Listening cover image

Is the century-long search for a weight loss drug over?

If You're Listening

00:00

Introduction

This chapter explores the sudden increase in value of Novo Nordisk, Europe's most valuable company, and the role of their drug semaglutide in treating type 2 diabetes and aiding weight loss, with endorsements from celebrities like Elon Musk and Amy Schumer.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app